Christopher M. Jewell

Christopher M. Jewell serves as an Associate Professor and Associate Chair for Research in the Fischell Department of Bioengineering at the University of Maryland College Park, with a secondary appointment in Microbiology and Immunology. His academic leadership includes strategic oversight of research initiatives within the department while maintaining an active laboratory focused on immune engineering.

Dr. Jewell's educational background includes:

• Visiting Scientist at Harvard University (2010-2011)
• Postdoctoral Fellow at MIT (2009-2012)
• Ph.D. from University of Wisconsin–Madison (2008)

His research program centers on engineering biomaterial-immune system interactions to develop next-generation therapies. Key interests include designing vaccine platforms using polyelectrolyte multilayers, creating nanotechnology-based drug carriers for autoimmune disease treatment, and developing synthetic immune tissues that reprogram lymph node microenvironments. This work bridges polymer chemistry, immunology, and translational medicine to address unmet needs in immunotherapy.

Analysis of Dr. Jewell's 2016-2018 publications reveals a cohesive research trajectory focused on spatial and temporal control of immune responses through engineered biomaterials. His team pioneered quantum dot systems for tuning antigen display density, microneedle arrays for localized T-cell expansion in melanoma, and polyelectrolyte scaffolds that induce antigen-specific tolerance. These studies consistently advance the integration of nanofabrication techniques with immunological principles to create precision therapeutic platforms.

No scientific awards were specified in the available documentation.

While specific advising activities and grant funding details were not provided, Dr. Jewell's role as Associate Chair for Research indicates significant administrative responsibilities alongside active mentorship of graduate students. His laboratory likely secures competitive research funding given the high-impact publications in journals like Nature Materials and Cell Reports.

Information regarding dedicated laboratory facilities or research teams was not included in the source text, though his departmental leadership position suggests oversight of collaborative research infrastructure within the Fischell Department of Bioengineering.